Bruker Corporation  

(Public, NASDAQ:BRKR)   Watch this stock  
Find more results for Flying Phoenix Corporation�
22.73
-0.92 (-3.89%)
Jul 31 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 22.63 - 23.49
52 week 17.75 - 24.93
Open 23.45
Vol / Avg. 465,661.00/633,957.00
Mkt cap 3.82B
P/E 45.99
Div/yield     -
EPS 0.49
Shares 167.87M
Beta 1.22
Inst. own 68%
Sep 8, 2014
Bruker Corp at Morgan Stanley Healthcare Conference - 8:00AM EDT - Add to calendar
Aug 6, 2014
Q2 2014 Bruker Corp Earnings Call - 4:45PM EDT - Add to calendar
Aug 6, 2014
Q2 2014 Bruker Corp Earnings Release - 4:00PM EDT - Add to calendar
Jun 18, 2014
Bruker Corp at Wells Fargo Healthcare Conference
Jun 2, 2014
Bruker Corporation at Jefferies Global Healthcare Conference
May 21, 2014
Bruker Corporation at UBS Global Healthcare Conference
May 20, 2014
Bruker Corporation Annual Shareholder Meeting
May 7, 2014
Q1 2014 Bruker Corporation Earnings Conference Call
May 7, 2014
Q1 2014 Bruker Corporation Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 2.36% 4.45%
Operating margin 4.86% 8.06%
EBITD margin - 12.61%
Return on average assets 2.00% 4.26%
Return on average equity 4.08% 10.32%
Employees 3,060 -
CDP Score - -

Address

40 MANNING RD
BILLERICA, MA 01821
United States - Map
+1-978-6633660 (Phone)
+1-978-6635585 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Bruker Corporation (Bruker) is a global manufacturer of scientific instruments that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications. The Company�s technology platforms include magnetic resonance technologies, mass spectrometry technologies, gas chromatography technologies, X-ray technologies, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology technology and infrared and Raman molecular spectroscopy technologies. Its manufacture and distribute a broad range of field analytical systems for chemical, biological, radiological, nuclear and explosives, or CBRNE, detection. In April 2012, it acquired SkyScan N.V. In September 2013, it announced that it has acquired Prairie Technologies, Inc. In July 2014, the Company acquired Vutara Incorporated.

Officers and directors

Frank H. Laukien Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 54
Bio & Compensation  - Reuters
Charles F. Wagner Jr. Chief Financial Officer, Executive Vice President
Age: 46
Bio & Compensation  - Reuters
Thomas W. Bachmann President of Bruker BioSpin Group
Age: 60
Bio & Compensation  - Reuters
Bernd Gewiese Ph.D. Co-President of Bruker BioSpin Corporation
Age: 55
Bio & Compensation  - Reuters
Werner E. Maas Ph.D. Co-President of Bruker BioSpin Corporation
Age: 49
Bio & Compensation  - Reuters
Mark R. Munch Ph.D. President, Bruker Nano Surfaces Division and Bruker MAT Group
Age: 52
Bio & Compensation  - Reuters
Juergen Srega President of Bruker CALID Group
Age: 59
Bio & Compensation  - Reuters
Anthony L. Mattacchione Senior Vice President - Corporate Finance and Accounting
Age: 51
Bio & Compensation  - Reuters
Michael Gunnar Knell Vice President - Finance, Chief Accounting Officer
Age: 37
Bio & Compensation  - Reuters
William A. Linton Lead Independent Director
Age: 66
Bio & Compensation  - Reuters